Christopher L. Jordan
Algemeen Adviseur bij CHIMERIX, INC.
Actieve functies van Christopher L. Jordan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHIMERIX, INC. | Algemeen Adviseur | 08-08-2022 | - |
Loopbaan van Christopher L. Jordan
Eerdere bekende functies van Christopher L. Jordan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENDOCYTE, INC. | Algemeen Adviseur | - | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| NOVARTIS AG | Algemeen Adviseur | - | - |
Opleiding van Christopher L. Jordan
| George Washington University | Graduate Degree |
| Purdue University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Zwitserland | 2 |
Operationeel
| General Counsel | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
